Lecanemab
- Commodity name： Lecanemab
Detailed description
- Product Description
-
Product Specifications
Product item number XC978994 -100μg English name Lecanemab Chinese name Lancrenabumab Antibody source Human Clone Type Monoclonal Physical State Liquid Concentration 1 mg/mL Subtype IgG1κ Expression system CHO-K1 stable cell line Purification method Affinity purified by Protein A Buffer solution 0.2 μm filtered in PBS, pH 7.4, 10% glycerol Purity ＞98% as determined by SDS-PAGE；＞98% as determined by SEC-HPLC Storage conditions
Aliquot and store at -20°C to -80°C,Avoid repeat freeze-thaw cycles.
Precautions
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
Product Introduction
Lecanemab is a humanized IgG1κ monoclonal antibody that targets soluble and insoluble amyloid β1–42 (Aβ) aggregates. Lecanemab is designed to bind to and clear amyloid-beta plaques in the brain. These plaques are believed to play a key role in the progression of Alzheimer's disease by disrupting communication between neurons and causing inflammation. By reducing amyloid buildup, the drug aims to slow cognitive decline in patients with early-stage Alzheimer's.
Documentary materials
Keywords:
Reference drug | Anti-drug antibodies | Instrument | Reagent
Related products
Anti-SN38 monoclonal antibody (Anti-SN38 mAb)
Product Number: XC992997 - 100 µg English Name: Anti-SN38 mAb Chinese Name: Anti-SN38 Monoclonal Antibody
View DetailsProduct Item Number: XC978994 - 100 μg English Name: Lecanemab Chinese Name: Luncanainadan Kang
View DetailsWelcome to leave us a message or inquiry.
Subscription Information
Subscribe to receive updates from Xichang News.
Shanghai Constream biotechnology Co., Ltd
Phone:021-59255902
Address: Building 2, Floors 2–3, Lane 10688, Beiqing Road, Qingpu District, Shanghai
WeChat Official Account
Copyright © 2026 Shanghai Constream biotechnology Co., Ltd.